← Back to Search

Dermal Filler

Dermal Filler for Chin Augmentation

N/A
Waitlist Available
Research Sponsored by Galderma R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after last treatment
Awards & highlights

Study Summary

This trial tests if Restylane Lyft with Lidocaine is as effective as a different chin augmentation treatment to improve chin profile.

Who is the study for?
This trial is for adults aged 22 or older who want to improve their chin profile through augmentation and correction of retrusion. It's not for those with allergies to hyaluronic acid gels, severe allergies like anaphylaxis, previous facial surgeries below the nose line, other aesthetic procedures in the area, or sensitivities to local anesthetics like lidocaine.Check my eligibility
What is being tested?
The study aims to show that Restylane Lyft with Lidocaine is just as safe and effective as another FDA-approved dermal filler when used for chin enhancement. Participants will receive injections intended to augment the chin region.See study design
What are the potential side effects?
Potential side effects may include reactions at the injection site such as redness, swelling, pain, bruising; allergic responses; and possibly lumps or asymmetry in the treated area.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after last treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after last treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Effectiveness Objective
Secondary outcome measures
Secondary Effectiveness Objective

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: New Dermal Filler for indicationExperimental Treatment1 Intervention
hyaluronic acid dermal filler
Group II: Active Comparator: FDA approved Dermal FillerActive Control1 Intervention
hyaluronic acid dermal filler
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
New Dermal Filler
2017
N/A
~280

Find a Location

Who is running the clinical trial?

Galderma R&DLead Sponsor
299 Previous Clinical Trials
60,246 Total Patients Enrolled
2 Trials studying Chin Retrusion
288 Patients Enrolled for Chin Retrusion
Study DirectorStudy DirectorGalderma R&D
1,211 Previous Clinical Trials
489,098 Total Patients Enrolled

Media Library

Restylane Lyft with Lidocaine (Dermal Filler) Clinical Trial Eligibility Overview. Trial Name: NCT05777759 — N/A
Chin Retrusion Research Study Groups: New Dermal Filler for indication, Active Comparator: FDA approved Dermal Filler
Chin Retrusion Clinical Trial 2023: Restylane Lyft with Lidocaine Highlights & Side Effects. Trial Name: NCT05777759 — N/A
Restylane Lyft with Lidocaine (Dermal Filler) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05777759 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What physical sites have been identified for conducting this research?

"12 clinical trial sites are presently offering this medication, including locations in Manhattan Beach, Westport and Aventura. To minimise travel demands for participants, selecting the closest site is recommended."

Answered by AI

Are there any vacant spots left in this research experiment for participants?

"By examining the clinicaltrials.gov database, we can verify that this medical trial is not taking on new patients at this moment in time. The initial post date was March 22nd 2023 and it has been updated as recently as March 9th of the same year. Nevertheless, there are 1 alternative trials which remain open for recruitment presently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
2023. "Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05777759.
~84 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top